Should your patient be PrEPared?

Clinical advancedment in HIV infection prevention is discussed. Preexposure prophylaxis (PrEP) using antiretroviral drugs is an evidence-based way to prevent new infections among patients at greatest risk of HIV infection. The only FDA-Approved PrEP option is an HIV mediation containing two nucleosi...

Full description

Saved in:

Bibliographic Details
Published in:	Nursing (Jenkintown, Pa.) Vol. 48; no. 3; p. 69
Main Authors:	Kerns, Rachel, Sheridan, Dan
Format:	Journal Article
Language:	English
Published:	United States Wolters Kluwer Health, Inc. All rights reserved 01-03-2018 Lippincott Williams & Wilkins Ovid Technologies
Subjects:	Antiretroviral drugs FDA approval HIV Human immunodeficiency virus Inhibitor drugs Medical treatment Nursing
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Clinical advancedment in HIV infection prevention is discussed. Preexposure prophylaxis (PrEP) using antiretroviral drugs is an evidence-based way to prevent new infections among patients at greatest risk of HIV infection. The only FDA-Approved PrEP option is an HIV mediation containing two nucleoside analogue HIV-1 reverse transcriptase inhibitors, emtricitabine and tenofovir disoproxil fumarate.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0360-4039 1538-8689
DOI:	10.1097/01.NURSE.0000530403.59535.ef